当前位置 : 洛杉矶时报增刊

Top pharmaceutical multinational steps up investment in Qingdao 发布日期:2023/8/30 来源:International daily 打印

The Management Committee of Qingdao National High-tech Industrial Development Zone and AstraZeneca Pharmaceuticals (Qingdao) Co., Ltd. recently entered into a framework agreement on strategic cooperation. According to the agreement, AstraZeneca plans to make an additional investment of USD250mln to the inhalation aerosol production and supply base program in Qingdao besides the previously injected USD450mln this March, to ramp up canning capacity and add another packaging line for inhalation aerosol.

“It is a great honor to join hands with Qingdao again to push bilateral cooperation to a higher level. AstraZeneca thinks highly of China’s production and supply lines in terms of resilience and capacity, and is impressed by China’s input into the bio-pharmaceutical industry. Shandong Province has long given play to its industrial strengths to prioritize developing the new and high-tech industry, particularly the bio-pharmaceutical industry. These efforts have created favorable conditions for us to build a world-class manufacturing base in China.” said Pan Bin, global executive vice president of AstraZeneca.  (Zhou Wei)


    24小时最新动态

    热点排行

    图片新闻

國際日報 (International Daily News)版權所有. 提醒:業者若未經許可,擅自引用國際日報網內容將面對法律行動. 第三方公司可能在國際日報網站宣傳他們的產品或服務, 您跟第三方公司的任何交易與國際日報網站無關,國際日報將不會對可能引起的任何損失負責. 信息網絡傳播視聽節目許可證:2032302 互聯網新聞信息服務許可證-45122353001  X公網安備 450103024350154號 互聯網出版許可證(X)字003號
©国际日报网版权所有